{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:52:59Z","timestamp":1760187179887},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2&3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>The Toll-like receptor 4 (TLR4) antagonists, (+)-naloxone and (+)-naltrexone, have been reported to decrease self-administration of opioids in rats and to reduce other preclinical indicators of abuse potential. However, under the self-administration conditions studied, the effects of TLR4 antagonists were not reinforcer selective, questioning the involvement of those receptors and their mediated inflammatory response specifically in opioid abuse. The objectives of the current study were to further characterize the reinforcer specificity of TLR4 antagonism in opioid self-administration and to explore its effects in a preclinical model of craving\/relapse. The TLR4 antagonist (+)-naltrexone decreased responding in rats trained to self-administer the \u00b5-opioid receptor agonist remifentanil, but with a potency that was not significantly different from that observed in another group of subjects in which responding was maintained by food reinforcement. Responding reinstated by heroin injection was decreased by (+)-naltrexone; however, a similar reduction was not reproduced with the administration of another TLR4 antagonist, lipopolysaccharide from <jats:italic toggle=\"yes\">Rhodobacter sphaeroides<\/jats:italic>, administered into the NAcc shell. Thus, TLR4 antagonists lacked reinforcer selectivity in reducing opioid self-administration and were not uniformly effective in a model of craving\/relapse, suggesting limitations on the development of (+)-naltrexone or TLR4 antagonists as treatments for opioid abuse.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000474","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T21:01:41Z","timestamp":1551387701000},"page":"186-195","source":"Crossref","is-referenced-by-count":14,"title":["A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids"],"prefix":"10.1097","volume":"31","author":[{"given":"Kai","family":"Yue","sequence":"first","affiliation":[{"name":"Psychobiology Section, Department of Health and Human Services, Molecular Neuropsychiatry Research Branch, Intramural Research Program"},{"name":"Wuhan Institute of Biomedical Science, Jianghan University, Wuhan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Tanda","sequence":"additional","affiliation":[{"name":"Medication Development Program, Department of Health and Human Services, Molecular Targets and Medication Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Katz","sequence":"additional","affiliation":[{"name":"Psychobiology Section, Department of Health and Human Services, Molecular Neuropsychiatry Research Branch, Intramural Research Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Zanettini","sequence":"additional","affiliation":[{"name":"Psychobiology Section, Department of Health and Human Services, Molecular Neuropsychiatry Research Branch, Intramural Research Program"},{"name":"Medication Development Program, Department of Health and Human Services, Molecular Targets and Medication Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2174\/1871527314666150529132503","article-title":"Targeting the toll of drug abuse: the translational potential of Toll-like receptor 4.","volume":"14","author":"Bachtell","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2017.08.003","article-title":"Glial and neuroinflammatory targets for treating substance use disorders.","volume":"180","author":"Bachtell","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1471-4159.1993.tb09814.x","article-title":"Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis\u2013Fischer strain differences in the rat ventral tegmental area.","volume":"61","author":"Beitner-Johnson","year":"1993","journal-title":"J Neurochem"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1523\/JNEUROSCI.0005-12.2012","article-title":"Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking.","volume":"32","author":"Bossert","year":"2012","journal-title":"J Neurosci"},{"key":"R5-20230910","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbi.2017.08.012","article-title":"Innate immune signaling in the ventral tegmental area contributes to drug-primed reinstatement of cocaine seeking.","volume":"67","author":"Brown","year":"2018","journal-title":"Brain Behav Immun"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/adb.12261","article-title":"The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers.","volume":"21","author":"Cooper","year":"2016","journal-title":"Addict Biol"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.drugalcdep.2017.04.029","article-title":"Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers.","volume":"178","author":"Cooper","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"R8-20230910","first-page":"393","article-title":"Studies on behavior. I. Differential sensitivity to pentobarbital of pecking performance in pigeons depending on the schedule of reward.","volume":"113","author":"Dews","year":"1955","journal-title":"J Pharmacol Exp Ther"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1749-6632.1999.tb09283.x","article-title":"Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell\/extended amygdala dopamine.","volume":"877","author":"Di Chiara","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.116.233544","article-title":"Comparison of (+)- and (\u2212)-Naloxone on the acute psychomotor-stimulating effects of heroin, 6-acetylmorphine, and morphine in mice.","volume":"358","author":"Eriksen","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1124\/jpet.111.185025","article-title":"Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and \u03c3 receptors.","volume":"339","author":"Hiranita","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).","volume":"28","author":"Hutchinson","year":"2008","journal-title":"Eur J Neurosci"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","article-title":"Opioid activation of toll-like receptor 4 contributes to drug reinforcement.","volume":"32","author":"Hutchinson","year":"2012","journal-title":"J Neurosci"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/jm00202a018","article-title":"Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone.","volume":"21","author":"Iijima","year":"1978","journal-title":"J Med Chem"},{"key":"R15-20230910","first-page":"1","article-title":"Determinants of the specificity of behavioral effects of drugs.","volume":"60","author":"Kelleher","year":"1968","journal-title":"Ergeb Physiol"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/npp.2017.82","article-title":"Opioid self-administration is attenuated by early-life experience and gene therapy for anti-inflammatory IL-10 in the nucleus accumbens of male rats.","volume":"42","author":"Lacagnina","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpain.2012.02.005","article-title":"(+)-Naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.","volume":"13","author":"Lewis","year":"2012","journal-title":"J Pain"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cmdc.201500188","article-title":"Therapeutic developments targeting toll-like receptor-4-mediated neuroinflammation.","volume":"11","author":"Li","year":"2016","journal-title":"ChemMedChem"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures.","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/npp.2017.70","article-title":"Effects of ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence.","volume":"42","author":"Metz","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1073\/pnas.92.26.12304","article-title":"Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the \u2018shell\u2019 as compared with the \u2018core\u2019 of the rat nucleus accumbens.","volume":"92","author":"Pontieri","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.2516-12.2013","article-title":"Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction.","volume":"33","author":"Schwarz","year":"2013","journal-title":"J Neurosci"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"17835","DOI":"10.1523\/JNEUROSCI.3297-11.2011","article-title":"Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression.","volume":"31","author":"Schwarz","year":"2011","journal-title":"J Neurosci"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3180-z","article-title":"FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration.","volume":"230","author":"Schwarz","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R26-20230910","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings.","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/bph.12028","article-title":"Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.","volume":"168","author":"Stevens","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1124\/jpet.104.080465","article-title":"Effects of 4\u2032-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.","volume":"313","author":"Tanda","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.106.118067","article-title":"Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.","volume":"321","author":"Tanda","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/npp.2016.91","article-title":"Lack of specific involvement of (+)-naloxone and (+)-naltrexone on the reinforcing and neurochemical effects of cocaine and opioids.","volume":"41","author":"Tanda","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biopsych.2012.12.019","article-title":"Effect of chronic delivery of the toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.","volume":"73","author":"Theberge","year":"2013","journal-title":"Biol Psychiatry"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.","volume":"173","author":"Wang","year":"2016","journal-title":"Br J Pharmacol"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.138.3537.143","article-title":"Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.","volume":"138","author":"Weeks","year":"1962","journal-title":"Science"},{"key":"R34-20230910","first-page":"75","article-title":"History of drug exposure as a determinant of drug self-administration.","volume":"37","author":"Young","year":"1981","journal-title":"NIDA Res Monogr"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T08:18:08Z","timestamp":1694333888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"journal-issue":{"issue":"2&3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000474","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}